Page last updated: 2024-11-08

1,3,5,7-cyclooctatetraene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,5,7-cyclooctatetraene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

[8]annulene : An antiaromatic annulene that is cyclooctane having four double bonds at positions 1, 3, 5 and 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID637866
CHEBI ID47034
MeSH IDM0528364

Synonyms (29)

Synonym
AKOS015840921
[8]annulene
nsc5093
629-20-9
cyclooctatetraene
nsc-5093
1,5,7-cyclooctatetraene
1,3,5,7-cyclooctatetraene
cyclooctatetraene [un2358] [flammable liquid]
COT ,
cyclooctatetraene, 98%
STK802308
cycloocta-1,3,5,7-tetraene
[8]-annulene
CHEBI:47034
unii-aj19r479cq
aj19r479cq ,
(8)annulene
nsc 5093
einecs 211-080-3
un2358
AKOS025311186
BBL027453
DTXSID9060867
KDUIUFJBNGTBMD-BONZMOEMSA-N
un 2358
cyclooctatetraene [mi]
mfcd00004161
VS-08539
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's10 (90.91)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.21 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.70 (4.65)
Search Engine Demand Index46.01 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]